JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2005) 187, 399-406       DOI: 10.1677/joe.1.06432
© 2005 Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Íseri, S O
Right arrow Articles by Yegen, B C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Íseri, S O
Right arrow Articles by Yegen, B C

Ghrelin against alendronate-induced gastric damage in rats

S Ö Íseri, G Sener1, M Yüksel3, G Contuk2, S Çetinel2, N Gedik4 and B Ç Yegen

Department of Physiology, Marmara University School of Medicine, Istanbul, Turkey
1 School of Pharmacy, Department of Pharmacology, Marmara University School of Medicine, Istanbul, Turkey
2 Department of Histology and Embryology, Marmara University School of Medicine, Istanbul, Turkey
3 Vocational School of Health Related Professions, Marmara University School of Medicine, Istanbul, Turkey
4 Division of Biochemistry, Kasimpasa Military Hospital, Istanbul, Turkey

(Requests for offprints should be addressed to B Ç Yeden, Department of Physiology, Marmara University School of Medicine, Haydarpasa, Istanbul 34668, Turkey; Email: byegen{at}marmara.edu.tr)

Alendronate sodium, a primary amino bisphosphonate, is widely used in the treatment of various diseases that are associated with bone resorption, such as postmenopausal osteoporosis and Paget’s disease of bone. Although the adverse effects of biphosphonates on the gastrointestinal system have been demonstrated in experimental and clinical studies, the exact mechanisms underlying this damage are not clear yet. Ghrelin, a 28 amino acid peptide produced predominantly by the stomach, was shown to exert a potent protective action on the stomach of rats exposed to ethanol or stress.

Our objective was to evaluate the possible anti-oxidant and anti-inflammatory effects of ghrelin against alendronate-induced gastric damage. Wistar albino rats were administered alendronate (20 mg/kg) by gavage for 4 days, along with either ghrelin (10 ng/kg per day) or saline given i.p. After decapitation, stomach tissues were removed for the determination of malondialdehyde (MDA) and glutathione (GSH) levels, myeloperoxidase (MPO) activity and tissue collagen content, while the extent of tissue damage was analyzed microscopically. Formation of reactive oxygen species was determined by chemiluminesence using a luminol probe in fresh gastric tissues. Serum tumor necrosis factor (TNF-{alpha}) and lactate dehydrogenase levels were assessed in trunk blood.

Oral administration of alendronate-induced significant gastric damage, accompanied by increased MPO activity, collagen content, MDA and luminol levels (P< 0.01–P< 0.001), while tissue GSH was decreased (P< 0.01). On the other hand, ghrelin treatment reversed these alterations (P< 0.05–P<0.001) as well as elevating serum TNF-{alpha} levels significantly (P< 0.001).

The findings of the present study suggest that alendronate induces oxidative gastric damage by a local irritant effect, and ghrelin ameliorates this damage by its possible antioxidant and anti-inflammatory properties.




This article has been cited by other articles:


Home page
EndocrinologyHome page
H. Chung, E. Kim, D. H. Lee, S. Seo, S. Ju, D. Lee, H. Kim, and S. Park
Ghrelin Inhibits Apoptosis in Hypothalamic Neuronal Cells during Oxygen-Glucose Deprivation
Endocrinology, January 1, 2007; 148(1): 148 - 159.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Endocrinology.